FR3053338B1 - Biomarqueur pour le diagnostic de maladies inflammatoires - Google Patents

Biomarqueur pour le diagnostic de maladies inflammatoires Download PDF

Info

Publication number
FR3053338B1
FR3053338B1 FR1656343A FR1656343A FR3053338B1 FR 3053338 B1 FR3053338 B1 FR 3053338B1 FR 1656343 A FR1656343 A FR 1656343A FR 1656343 A FR1656343 A FR 1656343A FR 3053338 B1 FR3053338 B1 FR 3053338B1
Authority
FR
France
Prior art keywords
biomarker
diagnosis
inflammatory diseases
disease
kits
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1656343A
Other languages
English (en)
Other versions
FR3053338A1 (fr
Inventor
Iain K Pemberton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip Res Consulting
Original Assignee
Ip Res Consulting
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ip Res Consulting filed Critical Ip Res Consulting
Priority to FR1656343A priority Critical patent/FR3053338B1/fr
Priority to PCT/FR2017/051811 priority patent/WO2018002564A1/fr
Publication of FR3053338A1 publication Critical patent/FR3053338A1/fr
Application granted granted Critical
Publication of FR3053338B1 publication Critical patent/FR3053338B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G01N2333/91215—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne l'utilisation d'un biomarqueur pour le diagnostic d'une maladie inflammatoire, en particulier des maladies inflammatoires chronique de l'intestin, une méthode de diagnostic, une méthode d'évaluation de l'efficacité d'un traitement, une méthode de dosage, ainsi que des kits et des substrats enzymatiques.
FR1656343A 2016-07-01 2016-07-01 Biomarqueur pour le diagnostic de maladies inflammatoires Expired - Fee Related FR3053338B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1656343A FR3053338B1 (fr) 2016-07-01 2016-07-01 Biomarqueur pour le diagnostic de maladies inflammatoires
PCT/FR2017/051811 WO2018002564A1 (fr) 2016-07-01 2017-07-03 Biomarqueur pour le diagnostic de maladies inflammatoires

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1656343 2016-07-01
FR1656343A FR3053338B1 (fr) 2016-07-01 2016-07-01 Biomarqueur pour le diagnostic de maladies inflammatoires

Publications (2)

Publication Number Publication Date
FR3053338A1 FR3053338A1 (fr) 2018-01-05
FR3053338B1 true FR3053338B1 (fr) 2021-01-22

Family

ID=56943747

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1656343A Expired - Fee Related FR3053338B1 (fr) 2016-07-01 2016-07-01 Biomarqueur pour le diagnostic de maladies inflammatoires

Country Status (2)

Country Link
FR (1) FR3053338B1 (fr)
WO (1) WO2018002564A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120231479A1 (en) * 2010-09-09 2012-09-13 Robert Puskas Combination methods of diagnosing cancer in a patient
US20140315194A1 (en) * 2011-04-20 2014-10-23 Traxxsson, Llc Methods of diagnosing cancer in a patient
US20140113306A1 (en) * 2012-10-17 2014-04-24 Rutgers, The State University Of New Jersey Diagnostic and screening methods for inflammation

Also Published As

Publication number Publication date
FR3053338A1 (fr) 2018-01-05
WO2018002564A1 (fr) 2018-01-04

Similar Documents

Publication Publication Date Title
MX2020001193A (es) Metodos para determinar dipeptidil peptidasa 3 y metodos terapeuticos.
BR112015023120A2 (pt) método para identificar um indivíduo com uma doença ou disfunção, método para prever a responsividade de um indivíduo com uma doença ou disfunção, método para determinar a probabilidade de que um indivíduo com uma doença ou disfunção exibirá benefício do tratamento, método para selecionar uma terapia, usos de um antagonista de ligação do eixo pd-l1, ensaio para identificar um indivíduo com uma doença, kit de diagnóstico, método para avaliar uma resposta ao tratamento e método para monitorar a resposta de um indivíduo tratado
MA40755B1 (fr) Compositions comprenant des souches bactériennes
MA45125B1 (fr) Anticorps anti-alpha-synucléine et leurs utilisations
GB2463401B (en) Characterizing prostate disorders by analysis of microvesicles
WO2013008102A3 (fr) Procédés et compositions pour évaluer et/ou traiter des maladies immunitaires chroniques
EA200971131A1 (ru) Биомаркеры для прогнозирования чувствительности или отсутствия чувствительности к анти-фно агентам
MA33747B1 (fr) Anticorps monoclonaux diriges contre la progastrine et leurs utilisations
EA201590630A1 (ru) Способы лечения и диагностики, связанные с лизилоксидазоподобным белком 2 (loxl2)
FR3021970B1 (fr) Anticorps dirige contre la galectine 9 et inhibiteur de l'activite suppressive des lymphocytes t regulateurs
WO2018007872A9 (fr) Biomarqueurs d'une affection abdominale inflammatoire
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
NZ729773A (en) Biomarkers for disease progression in melanoma
BR112017025995A2 (pt) inibidor de igfbp3, composição farmacêutica para uso no tratamento e/ou prevenção de um distúrbio intestinal, método para o diagnóstico de um distúrbio intestinal em um indivíduo e kit para o diagnóstico de um distúrbio intestinal
GB0711327D0 (en) Diagnostic method
WO2018096375A3 (fr) Méthode de détermination de l'état réceptif de l'endomètre
MX2018001697A (es) Método para la cuantificación de los miembros del filogrupo i y/o del filogrupo ii de faecalibacterium prausnitzii y el uso de los mismos como biomarcadores.
MA35173B1 (fr) Anticorps anti-cxcr4 ayant des fonctions effectrices et son utilisation pour le traitement du cancer
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3974450A3 (fr) Biomarqueur
WO2015013508A3 (fr) Procédés permettant de diagnostiquer et de traiter une maladie du système immunitaire
BR112019024661A2 (pt) Isolamento de células de origem epitelial circulantes no sangue periférico
WO2014153232A3 (fr) Méthodes et compositions pour diagnostiquer une prééclampsie
FR3053338B1 (fr) Biomarqueur pour le diagnostic de maladies inflammatoires
MX2021009247A (es) Metodos, sistemas y kits para tratar enfermedades inflamatorias que se dirigen a il18r1.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20180105

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20230305